Intra-ovarian CAPA-IVM vs Standard IVM
NCT: NCT07858435 · NOT_YET_RECRUITING
Brief Summary
This prospective study compares two approaches to obtaining mature oocytes for fertility treatment within the same participant. Immature oocytes are first retrieved from the right ovary and matured in the laboratory using a two-step biphasic capacitation in vitro maturation method (CAPA-IVM). Beginning on Day 5 of the same menstrual cycle, the left ovary undergoes minimal controlled ovarian stimulation followed by routine oocyte retrieval and IVF/ICSI. The primary objective is to evaluate the maturation of CAPA-IVM oocytes to the metaphase II (MII) stage and compare reproductive laboratory outcomes between the CAPA-IVM and minimal-stimulation OS-IVF approaches. Secondary outcomes include fertilization, embryo development, blastocyst formation, embryo quality, pregnancy and live birth outcomes, and safety.
Frequently Asked Questions
What is Intra-ovarian CAPA-IVM vs Standard IVM?
Intra-ovarian CAPA-IVM vs Standard IVM is a clinical trial registered under NCT07858435. Current status: NOT_YET_RECRUITING.
What is the status of NCT07858435?
The current status of NCT07858435 (Intra-ovarian CAPA-IVM vs Standard IVM) is: NOT_YET_RECRUITING.
When did Intra-ovarian CAPA-IVM vs Standard IVM start?
Intra-ovarian CAPA-IVM vs Standard IVM started on 2026-10.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.